Concepedia

Author

Wei Deng

Chinese Academy of Medical Sciences & Peking Union Medical CollegeORCID

Also Known As

Deng, Wei, W. Deng, WEI MIN DENG, Wei Deng

151

Publications

2.3K

Citations

28

H-Index

41

Concepts

All Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical CollegeNRG OncologyPeking UniversityMemorial Sloan Kettering Cancer CenterPeking University Cancer Hospital
WD

About

Wei Deng is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

14

924

2

Health Sciences

4

4

541

3

Public Health

3

3

202

4

Epidemiology

1

1

32

5

Gastroenterology

1

1

61

Wei Deng

×

45

Publications

1.8K

Citations

26

H-Index

YearCitations

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis

Ruben A. Mesa, Jean‐Jacques Kiladjian, John Catalano,

Journal of Clinical Oncology

2017

345

Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)

Alessandro D. Santin, Wei Deng, Michael Frumovitz,

Gynecologic Oncology

2020

149

The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy

Wei Deng, Xu Cai, Amy Liu,

Radiotherapy and Oncology

2019

82

Long‐term safety and efficacy of deferasirox (Exjade<sup>®</sup>) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease

Elliott Vichinsky, Françoise Bernaudin, Gian Luca Forni,

British Journal of Haematology

2011

78

A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix

Charles A. Kunos, Wei Deng, Dawn Dawson,

International Journal of Gynecological Cancer

2015

63

Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram

Peter S.N. van Rossum, Wei Deng, David M. Routman,

Practical Radiation Oncology

2019

61

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Angeles Alvarez Secord, Kirsten B. Burdett, Kouros Owzar,

Clinical Cancer Research

2020

55

Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy

Wei Deng, Wencheng Zhang, Jinsong Yang,

Annals of Surgical Oncology

2019

53

Technical Note: Integrating an open source Monte Carlo code “MCsquare” for clinical use in intensity‐modulated proton therapy

Wei Deng, James E. Younkin, Kevin Souris,

Medical Physics

2020

50

Small‐spot intensity‐modulated proton therapy and volumetric‐modulated arc therapies for patients with locally advanced non‐small‐cell lung cancer: A dosimetric comparative study

Chenbin Liu, Terence T. Sio, Wei Deng,

Journal of Applied Clinical Medical Physics

2018

46

Page 1